Please contact Colleen O’Malley, Sr. Director, Marketing & Communications, ABTA at 773-577-8750.
ABTA Press Releases
The American Brain Tumor Association (ABTA) today announced the funding of $427,000 towards 17 new 2021 research grants to improve brain tumor science and discovery. With more than $33.5 million invested in research to date, across all brain tumor types and ages, the ABTA research program plays a critical role in advancing treatments and ushering in the next generation of brain tumor researchers.
A first-of-its-kind, cross-sectional survey of patients, caregivers and physicians on the diagnosis and treatment of brain metastases, conducted by the American Brain Tumor Association (ABTA), as part of its Metastatic Brain Tumor Initiative, revealed disparities in practice patterns and communication around metastatic brain tumors. These data highlight the need to increase accessibility to clinical trials, establish clear standards of care and improve physician-patient communication reflective of the unique needs of patients with brain metastases (BM). The survey results have been published open access in the journal Neuro-Oncology Practice.
The American Brain Tumor Association (ABTA) persists in its mission, announcing today the investment of $368,000 towards 11 new research grants to foster innovation in diagnosis and treatment of brain tumors in adults and children.
American Brain Tumor Association (ABTA) today announced a new partnership with the Southeastern Brain Tumor Foundation (SBTF) to accelerate brain tumor research. Through this partnership, the Southeastern Brain Tumor Foundation will invest $50,000 in the ABTA research program to fund one glioblastoma immunotherapy research project.